Results for: Share Price

Wipro’s share price has been facing a downward trend, dropping 15% from its one-year high and underperforming compared to peers like TCS and Infosys. The release of Q4 results, which showed a decline in consolidated net profit and revenue, has raised concerns among investors and analysts. Experts believe that Wipro is facing demand uncertainties and challenges in timely deal ramp-up. Despite this, the share has shown resilience compared to its 52-week low and has rebounded by over 27%. Analysts recommend cautious optimism as Wipro navigates the current market environment.

Vaxxinity (NASDAQ: VAXX) announced plans to voluntarily delist its shares from the Nasdaq Exchange. The company will file for delisting on April 29, 2024, expecting its final day of trading on Nasdaq to be May 9, 2024. Vaxxinity received a delisting notice in February requiring it to get its share price above $1 by August 7, 2024. The company chose to delist early to reduce its obligations and save money. Despite the delisting, VAXX stock is expected to continue trading on OTC Markets after May 9.